228 related articles for article (PubMed ID: 28122556)
21. Contemporary Management of Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
Magistro G; Wagenlehner FM; Grabe M; Weidner W; Stief CG; Nickel JC
Eur Urol; 2016 Feb; 69(2):286-97. PubMed ID: 26411805
[TBL] [Abstract][Full Text] [Related]
22. Effect of thermophilic bacterium HB27 manganese superoxide dismutase in a rat model of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).
Chen NW; Jin J; Xu H; Wei XC; Wu LF; Xie WH; Cheng YX; He Y; Gao JL
Asian J Androl; 2022; 24(3):323-331. PubMed ID: 34747725
[TBL] [Abstract][Full Text] [Related]
23. Melatonin attenuates prostatic inflammation and pelvic pain via Sirt1-dependent inhibition of the NLRP3 inflammasome in an EAP mouse model.
Chen J; Zhang LG; Du HX; Zhan CS; Liu Y; Zhang M; Chen XG; Wen LP; Zhang L; Liang CZ
Prostate; 2021 Nov; 81(15):1179-1190. PubMed ID: 34418127
[TBL] [Abstract][Full Text] [Related]
24. Investigation of the effect of traditional Chinese medicine on pain and inflammation in chronic nonbacterial prostatitis in rats.
Liu YJ; Song GH; Liu GT
Andrologia; 2016 Aug; 48(6):714-22. PubMed ID: 26840892
[TBL] [Abstract][Full Text] [Related]
25. [Clinical study on treatment of chronic prostatitis/chronic pelvic pain syndrome by three different TCM principles].
Zhang MJ; Chu KD; Shi YL
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Nov; 27(11):989-92. PubMed ID: 18173143
[TBL] [Abstract][Full Text] [Related]
26. α-blockers, antibiotics and anti-inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome.
Thakkinstian A; Attia J; Anothaisintawee T; Nickel JC
BJU Int; 2012 Oct; 110(7):1014-22. PubMed ID: 22471591
[TBL] [Abstract][Full Text] [Related]
27. [Lycopene combined with quercetin and curcumin for chronic prostatitis/chronic pelvic pain syndrome in rats: Effect and mechanism].
Zhao QX; Yang FY; Chen D; Xing NZ
Zhonghua Nan Ke Xue; 2021 Feb; 27(2):99-105. PubMed ID: 34914324
[TBL] [Abstract][Full Text] [Related]
28. Sodium butyrate alleviates experimental autoimmune prostatitis by inhibiting oxidative stress and NLRP3 inflammasome activation via the Nrf2/HO-1 pathway.
Hua X; Zhang J; Chen J; Feng R; Zhang L; Chen X; Jiang Q; Yang C; Liang C
Prostate; 2024 May; 84(7):666-681. PubMed ID: 38444115
[TBL] [Abstract][Full Text] [Related]
29. Extracorporeal shock wave therapy decreases the number of total and degranulated mast cells and alleviates pelvic pain in a rat model of prostatitis.
Song Z; Jin C; Bian Z; Liang C
Mol Cell Biochem; 2021 Apr; 476(4):1905-1913. PubMed ID: 33492609
[TBL] [Abstract][Full Text] [Related]
30. Bladder sensation evaluation of a carrageenan-induced chronic prostatitis model using a direct measurement of the bladder mechanosensitive single-unit afferent nerve activity.
Aizawa N; Yamanishi T; Fujita T
Neurourol Urodyn; 2020 Nov; 39(8):2111-2119. PubMed ID: 32725829
[TBL] [Abstract][Full Text] [Related]
31. Chronic prostatitis/chronic pelvic pain syndrome impairs erectile function through increased endothelial dysfunction, oxidative stress, apoptosis, and corporal fibrosis in a rat model.
Hu Y; Niu X; Wang G; Huang J; Liu M; Peng B
Andrology; 2016 Nov; 4(6):1209-1216. PubMed ID: 27565759
[TBL] [Abstract][Full Text] [Related]
32. The role of nutraceutical medications in men with non bacterial chronic prostatitis and chronic pelvic pain syndrome: A prospective non blinded study utilizing flower pollen extracts versus bioflavonoids.
Maurizi A; De Luca F; Zanghi A; Manzi E; Leonardo C; Guidotti M; Antonaccio FP; Olivieri V; De Dominicis C
Arch Ital Urol Androl; 2019 Jan; 90(4):260-264. PubMed ID: 30655636
[TBL] [Abstract][Full Text] [Related]
33. Li-ESWT treatment reduces inflammation, oxidative stress, and pain via the PI3K/AKT/FOXO1 pathway in autoimmune prostatitis rat models.
Feng B; Dong Z; Wang Y; Yan G; Yang E; Cheng H; Liang C; Hao Z; Zhang X; Song Z; Jiang Z; Chen M; Yue Z; Wang Z
Andrology; 2021 Sep; 9(5):1593-1602. PubMed ID: 33960707
[TBL] [Abstract][Full Text] [Related]
34. Quercetin protects against chronic prostatitis in rat model through NF-κB and MAPK signaling pathways.
Meng LQ; Yang FY; Wang MS; Shi BK; Chen DX; Chen D; Zhou Q; He QB; Ma LX; Cheng WL; Xing NZ
Prostate; 2018 Aug; 78(11):790-800. PubMed ID: 29654614
[TBL] [Abstract][Full Text] [Related]
35. Prostate extract with aluminum hydroxide injection as a novel animal model for chronic prostatitis/chronic pelvic pain syndrome.
Qi X; Han L; Liu X; Zhi J; Zhao B; Chen D; Yu F; Zhou X
Urology; 2012 Dec; 80(6):1389.e9-15. PubMed ID: 23017785
[TBL] [Abstract][Full Text] [Related]
36. [Qiantongding Decoction: An efficacious therapeutic for type III B prostatitis].
Chen DN; Chen WT; Ma QH; Qin Z; Huang ZW
Zhonghua Nan Ke Xue; 2009 Jan; 15(1):89-91. PubMed ID: 19288755
[TBL] [Abstract][Full Text] [Related]
37. Experimental study on anti-inflammatory activity of a TCM recipe consisting of the supercritical fluid CO2 extract of Chrysanthemum indicum, Patchouli Oil and Zedoary Turmeric Oil in vivo.
Su JY; Tan LR; Lai P; Liang HC; Qin Z; Ye MR; Lai XP; Su ZR
J Ethnopharmacol; 2012 Jun; 141(2):608-14. PubMed ID: 21920423
[TBL] [Abstract][Full Text] [Related]
38. Differential expression of immune factor between patients with chronic prostatitis/chronic pelvic pain syndrome and the healthy volunteers.
Ye C; Xiao G; Xu J; Qin S; Luo Y; Chen G; Lai HH; Zhou T
Int Urol Nephrol; 2018 Mar; 50(3):395-399. PubMed ID: 29235061
[TBL] [Abstract][Full Text] [Related]
39. Penetration and pharmacokinetics of non-steroidal anti-inflammatory drugs in rat prostate tissue.
Yellepeddi VK; Radhakrishnan J; Radhakrishnan R
Prostate; 2018 Feb; 78(2):80-85. PubMed ID: 29105796
[TBL] [Abstract][Full Text] [Related]
40. [Efficacy and safety of Longjintonglin Capsule for the treatment of type III prostatitis].
Shang XJ; Geng Q; Duan JM; Zheng DQ; Xie L; Guo J
Zhonghua Nan Ke Xue; 2014 Dec; 20(12):1109-12. PubMed ID: 25597179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
